PMC3589773_01
The Inhibitor Assay of Patient During Treatment
ircmj-15-18-i001.jpg
PMC3589773_01_ircmj-15-18-i001.jpg
fig1423
The inhibitor level reduced to 3.1 BU/ml after three months, to 1.6 BU/ml after 6 months, with complete remission within one year of treatment (Figure 1).